MoneyWorks4Me

Sun Pharmaceutical Industries informs about disclosure

21 May 2020 Evaluate

Sun Pharmaceutical Industries has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 20, 2020 for Shanghvi Finance.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1801.00
Dr. Reddys Labs. 1209.15
Cipla 1343.00
Lupin 2035.00
Zydus Lifesciences 1160.00
View more..